NYSE:TMOLife Sciences
Thermo Fisher Scientific (TMO) Valuation Check As Obesity Registry And Key Investor Events Draw Focus
Thermo Fisher Scientific (TMO) has drawn fresh investor attention after enrolling the first patient in its new PPD CorEvitas Obesity Registry, alongside interest in the CEO’s upcoming J.P. Morgan Healthcare Conference appearance and Q4 earnings.
See our latest analysis for Thermo Fisher Scientific.
Those obesity registry headlines come as Thermo Fisher’s share price sits at US$606.50, with a 7 day share price return of 4.67% and a 90 day share price return of 15.57%. The 1 year total...